For over 40 years, Anomet Products has focused exclusively on manufacturing innovative clad-metal wire composite solutions that deliver optimized performance for the most demanding applications. Our goal has always been to provide superior material quality, product value and customer satisfaction through service and support that far exceed expectations. We’re proud that this unwavering commitment has fostered strong, collaborative partnerships with leading OEMs across an extremely diverse range of business sectors, including aerospace & defense, automotive, battery & fuel cell technology, energy production (oil & gas), appliances, corrosion protection, industrial, electronic, superconductors, medical devices and electrochemical.
Boston Biomedical, Inc. is a leading developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. As a fully integrated oncology drug research and development company, Boston Biomedical, Inc. has established a track record of accomplishments, including advancing the research and development of multiple compounds and clinical programs. The company’s range of expertise includes drug discovery, medicinal chemistry, preclinical development, pharmacology, pharmaceutical development, CMC (chemistry, manufacturing, and control), global clinical trials, regulatory affairs and commercialization.
Greenberg Traurig, LLP has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
Created in 1979 by the healthcare technology industry, Medmarc’s purpose is to be the superior provider of liability insurance and related risk management solutions and to support the development, testing and delivery of medical products that save lives and improve the quality of life. Through collaboration with our parent company, ProAssurance, and our clinical trial industry experts, we provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve. From ideas and prototypes to the reality of commercialization and success – We can Meet Your Changing Needs. Call me, George Ayd (800) 356-6886, to discuss the cost of insurance coverage, what coverages are needed and when, for your business plan.
Toxikon is a preclinical contract research organization. We contract and partner with biotech, pharmaceutical and medical device industries to deliver exceptional product development services from concept to final product.